ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) Technical Analysis
NASDAQ:CNCR • US26922A8264
Current stock price
CNCR Technical Rating and Analysis
Overall CNCR gets a technical rating of 0 out of 10. CNCR scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
- The long term trend is still negative, but the short term trend is neutral. It is advised to wait a little bit longer to see how this turns out.
- 91% of all other stocks performed better in the past year than CNCR.
- CNCR is currently trading in the lower part of its 52 week range. The S&P500 Index however is trading in the upper part of its 52 week range, so CNCR is lagging the market.
- Warning: CNCR has an average volume of 2084 traded shares per day. This is quite low and it might be dangerous to invest in illiquid stocks.
- In the last month CNCR has a been trading in the 8.67 - 10.30 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
CNCR Weekly and Daily overview Charts
CNCR Setup Rating and Analysis
The technical rating of CNCR is bad and it also does not present a quality setup at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
CNCR Support and Resistance Analysis
8.80
We found 1 important support area.
- A support zone ranging from 8.89 to 8.91. This zone is formed by a combination of multiple trend lines and important moving averages in the daily time frame.
4 important resistance areas can be observed.
- A resistance zone ranging from 9.34 to 9.48. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- A resistance zone ranging from 9.74 to 9.84. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- A resistance zone ranging from 10.18 to 10.18. This zone is formed by a combination of multiple trend lines in multiple time frames.
- Resistance @13.82 from a trend line in the weekly time frame.
CNCR Technical Indicator Signal Analysis
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for CNCR is down. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for CNCR is neutral. |
| ChartMill Relative Strength | 9.91 | NEGATIVE | CNCR has a low relative strength, it was outperformed by 90.09% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of CNCR is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of CNCR is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of CNCR is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 46.36 | NEUTRAL | The RSI value for CNCR is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.01 | POSITIVE | The MACD value suggests CNCR has a positive trend. |
| Stochastics (14,3) | 27.92 | NEUTRAL | The Stochastics value for CNCR is a neutral value. |
| Average True Range in percent/ATR (20) | 2.85 | MEDIUM VOLATILITY | The ATR as a percentage value for CNCR suggests some volalility. |
| Average Directional Index/ADX (14) | 22.82 | NEUTRAL | The ADX value for CNCR suggests a possible start of a new trend. |
CNCR Chart- and CandleStick Pattern Analysis
CNCR Technicals: Chart, Performance Metrics, Trend & Indicators
ETF Series Solutions Trust Range Cancer Therapeutics
NASDAQ:CNCR (5/27/2025, 8:11:47 PM)
After market: 9.32 +0.3 (+3.33%)9.02
+0.14 (+1.58%)
ETF Series Solutions Trust Range Cancer Therapeutics / CNCR TA FAQ
What is the technical rating for CNCR stock?
ChartMill assigns a technical rating of 0 / 10 to CNCR.
Can you provide the trend direction for ETF Series Solutions Trust Range Cancer Therapeutics?
The current trend direction for ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) is Bearish.
Can you provide the RSI signal for ETF Series Solutions Trust Range Cancer Therapeutics?
ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) has an RSI value of 46.3639. This indicates that the stock is currently neutral.
Can you provide the short term momentum for ETF Series Solutions Trust Range Cancer Therapeutics?
The short term momentum for ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) is neutral.
What is the support and resistance level for CNCR stock?
ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) has a support level at 8.91 and a resistance level at 9.34. Check the full technical report for our detailed analysis of CNCR support and resistance levels.